Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 8Colorectal Neoplasms 6Neoplasm Metastasis 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Thyroid Neoplasms 1Rectal Neoplasms 1Kidney Neoplasms 1Histiocytosis 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma 1Brain Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 4Magnetic Resonance Spectroscopy 4trametinib 3selpercatinib 3Trastuzumab 3ulixertinib 2larotrectinib 2binimetinib 2belinostat 2alectinib 2Sunitinib 2Specimen Handling 2Radiotherapy 2Paclitaxel 2Nivolumab 2Fluorouracil 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Biopsy 2130-nm albumin-bound paclitaxel 2vandetanib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1tislelizumab 1tipifarnib 1spartalizumab 1sargramostim 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Panitumumab × Thoracic × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡